These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Integration of Food Animal Residue Avoidance Databank (FARAD) empirical methods for drug withdrawal interval determination with a mechanistic population-based interactive physiologically based pharmacokinetic (iPBPK) modeling platform: example for flunixin meglumine administration. Li M; Cheng YH; Chittenden JT; Baynes RE; Tell LA; Davis JL; Vickroy TW; Riviere JE; Lin Z Arch Toxicol; 2019 Jul; 93(7):1865-1880. PubMed ID: 31025081 [TBL] [Abstract][Full Text] [Related]
3. Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans. Lin Z; Li M; Gehring R; Riviere JE J Pharm Sci; 2015 Jan; 104(1):233-43. PubMed ID: 25407474 [TBL] [Abstract][Full Text] [Related]
5. Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Zhao P; Zhang L; Grillo JA; Liu Q; Bullock JM; Moon YJ; Song P; Brar SS; Madabushi R; Wu TC; Booth BP; Rahman NA; Reynolds KS; Gil Berglund E; Lesko LJ; Huang SM Clin Pharmacol Ther; 2011 Feb; 89(2):259-67. PubMed ID: 21191381 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment. Clewell HJ; Gentry PR; Gearhart JM J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182 [TBL] [Abstract][Full Text] [Related]
7. Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment. Andersen ME Toxicol Lett; 1995 Sep; 79(1-3):35-44. PubMed ID: 7570672 [TBL] [Abstract][Full Text] [Related]
8. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification. Sager JE; Yu J; Ragueneau-Majlessi I; Isoherranen N Drug Metab Dispos; 2015 Nov; 43(11):1823-37. PubMed ID: 26296709 [TBL] [Abstract][Full Text] [Related]
9. Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine. Buur J; Baynes R; Smith G; Riviere J Antimicrob Agents Chemother; 2006 Jul; 50(7):2344-51. PubMed ID: 16801411 [TBL] [Abstract][Full Text] [Related]
10. Isoherranen N Drug Metab Dispos; 2024 Feb; ():. PubMed ID: 38326033 [TBL] [Abstract][Full Text] [Related]
11. The application of allometric scaling principles to predict pharmacokinetic parameters across species. Huang Q; Riviere JE Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1241-53. PubMed ID: 24984569 [TBL] [Abstract][Full Text] [Related]
12. Application of physiologically based pharmacokinetic models to promote the development of veterinary drugs with high efficacy and safety. Zhou K; Mi K; Ma W; Xu X; Huo M; Algharib SA; Pan Y; Xie S; Huang L J Vet Pharmacol Ther; 2021 Sep; 44(5):663-678. PubMed ID: 34009661 [TBL] [Abstract][Full Text] [Related]
13. Mathematical modeling and simulation in animal health. Part I: Moving beyond pharmacokinetics. Riviere JE; Gabrielsson J; Fink M; Mochel J J Vet Pharmacol Ther; 2016 Jun; 39(3):213-23. PubMed ID: 26592724 [TBL] [Abstract][Full Text] [Related]
14. Performance Assessment and Translation of Physiologically Based Pharmacokinetic Models From acslX to Berkeley Madonna, MATLAB, and R Language: Oxytetracycline and Gold Nanoparticles As Case Examples. Lin Z; Jaberi-Douraki M; He C; Jin S; Yang RSH; Fisher JW; Riviere JE Toxicol Sci; 2017 Jul; 158(1):23-35. PubMed ID: 28402537 [TBL] [Abstract][Full Text] [Related]
15. Physiologically-based pharmacokinetic (PBPK) models in toxicity testing and risk assessment. Lipscomb JC; Haddad S; Poet T; Krishnan K Adv Exp Med Biol; 2012; 745():76-95. PubMed ID: 22437814 [TBL] [Abstract][Full Text] [Related]
16. Toxicokinetic modeling and its applications in chemical risk assessment. Andersen ME Toxicol Lett; 2003 Feb; 138(1-2):9-27. PubMed ID: 12559690 [TBL] [Abstract][Full Text] [Related]
17. Current models in pharmacokinetics: applications in veterinary pharmacology. Kinabo LD; McKellar QA Vet Res Commun; 1989; 13(2):141-57. PubMed ID: 2672556 [TBL] [Abstract][Full Text] [Related]
19. Challenges Associated With Applying Physiologically Based Pharmacokinetic Modeling for Public Health Decision-Making. Tan YM; Worley RR; Leonard JA; Fisher JW Toxicol Sci; 2018 Apr; 162(2):341-348. PubMed ID: 29385573 [TBL] [Abstract][Full Text] [Related]